Alembic Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr. Chirayu Amin as Executive Chairman of the company w.e.f. April 01, 2026.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alembic Pharmaceuticals has formally appointed Mr. Chirayu Amin as Executive Chairman of the company effective April 1, 2026, for a 5-year term. The appointment was earlier approved by shareholders at the 15th Annual General Meeting held on August 5, 2025. Mr. Chirayu Amin, who previously held the combined role of Chairman & CEO, has relinquished the CEO position upon completion of his earlier tenure on March 31, 2026. The company confirmed he is not debarred by SEBI or any other authority from holding a director's position. He holds a science degree from Maharaja Sayajirao University of Baroda and an MBA from Seton Hall University, USA.
This is a planned internal transition within the promoter family — Mr. Chirayu Amin moves from Chairman & CEO to Executive Chairman, while his two sons, Pranav Amin and Shaunak Amin, continue as Managing Directors. Shareholders can expect leadership continuity with no disruption to the company's strategic direction.